Return Peptide Library
Eptifibatide
BLevel 1 evidenceEptifibatide
Cardiovascular and Vasoactive Peptides
Basic Information
Categories
GP IIb/IIIa receptor antagonists
Overview
FDA approves synthetic cyclic heptapeptide GP IIb/IIIa receptor antagonist derived from rattlesnake venom.
Efficacy Rating
FDA-approved, antiplatelet
Evidence Level
Grade B
Evidence Type
No data available
Confidence
No data available
China Regulatory Status
Cosmetic Ingredient Directory
No data available
Food/Supplements
No data available
Medicine
No data available
Similar Peptide Recommendations
Adrenomedullin
Adrenomedullin
BCardiovascular and Vasoactive Peptides
endogenous, vasodilator, sepsis
Angiotensin-(1-7)
Angiotensin-(1-7)
BCardiovascular and Vasoactive Peptides
Endogenous, Cardiovascular, RAAS
Bivalirudin
Bivalirudin
BCardiovascular and Vasoactive Peptides
FDA-approved anticoagulant
Endothelin-1
Endothelin-1
BCardiovascular and Vasoactive Peptides
Endogenous, vasoconstrictor, cardiovascular
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.